Vaginal Dryness Clinical Trial
Official title:
Evaluation Of Acceptability, Under Use in Real Conditions Of Two Vaginal Moistures ( 06260308 ) Indicated for Women With Vaginal Drying
The studies carried out to evaluate the safety and efficacy of products aimed at the intimate
area of women aim to confirm the absence of risk associated with its use, identify possible
feelings of discomfort and / or clinical signs resulting from the use of the product and
evaluate the benefits provided by the use of the product such as, gynecologically tested,
clinically tested, hydration for 72 hours, hydration, does not drip or drip little, feeling
of natural hydration, control of natural vaginal odor, preserves vaginal pH, does not promote
irritation, use vaginal topic, feeling of comfort, relief from dryness, easy use of the
applicator, the applicator does not cause discomfort during application, preferably use at
night, does not change the vaginal flora, reduces pain and discomfort during or shortly after
sexual intercourse, does not promote discomfort during or shortly after intercourse,
reduction of vaginal bleeding during or right after sexual intercourse, if there is a small
amount left in the applicator, the treatment is not compromised.
The research will be carried out with two new products for use in the internal intimate
region in up to 74 research participants (up to 37 participants per product - each group of
37 will use one of the products), which meet the required inclusion and exclusion criteria.
At the end of the treatment, the analysis must contain a minimum number of 30 participants
per product. Participants will use the test products for 22 (+ 2) days and will be evaluated
and monitored throughout the study by a gynecologist to verify the effectiveness of the
products and possible adverse events. In addition, a profile questionnaire will be applied at
the beginning of the study (T0 - day 1) and at the end of the study, the perceived efficacy
questionnaire (T22), to assess signs and symptoms of the efficacy and safety of the product
used.
Moisturizers are used in chronic maintenance, replacing normal vaginal sections.
Vaginal moisturizers rehydrate the mucosal tissue and are absorbed by the skin, adhering to
the vaginal lining, thus mimicking natural vaginal secretions. The use of vaginal
moisturizers is intended to allow dryness / atrophy, vaginitis / non-hormonal vaginal atrophy
and is regularly harmful or once every 2-3 days. The frequency of use is directly
proportional to the severity of the atrophy (for example, the more severe the atrophy, the
more frequent the application is), the effects of the moisturizer are more prolonged and the
effects of the lubricant, lasting 2 to 3 days.
MOD_PRO_CEP Rev. 03 All-SE-UG-EP-pH-FL-062603-07 / 08-04-18-PRV01 Vaginal moisturizers use
this longer to change the content of the endothelium fluid, capture the vaginal pH and thus
maintain vaginal hydration and acidity. Therefore, they are particularly beneficial, not only
for women with VVA / GSM symptoms that cause pain during intercourse, but also for women who
are not currently sexually active, but experience discomfort on a daily basis. Since vaginal
moisturizers are used to moisturize the mucosa, most contain water. For the water to stick to
the mucosa, it also contains vegetable or synthetic polymers. In addition, they can use a
wide variety of other excipients to provide adequate viscosity, to buffer or pH and for
conservation; these additional ingredients (some synthetic polymers) affect the pH and
osmolality of the moisturizer.
The products to be tested in this study are two vaginal moisturizers. These are two new
products from the sponsor.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01170195 -
Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03666819 -
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
|
Phase 2 | |
Completed |
NCT02937805 -
Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes
|
N/A | |
Completed |
NCT02994342 -
Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness
|
N/A | |
Recruiting |
NCT05913479 -
Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer
|
N/A | |
Completed |
NCT03307044 -
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
|
N/A | |
Recruiting |
NCT03714581 -
Laser Therapy Following Radiotherapy for Gynecological Cancer
|
N/A | |
Completed |
NCT01948583 -
Humectant Activity of a New Formulation of Gynomunal® Vaginalgel
|
Phase 4 | |
Completed |
NCT03178825 -
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
|
N/A | |
Completed |
NCT03372720 -
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
|
N/A | |
Not yet recruiting |
NCT06282614 -
Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
|
N/A | |
Completed |
NCT02176083 -
Reproductive Health Survivorship Care Plan Pilot
|
N/A | |
Completed |
NCT04908124 -
A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants.
|
Phase 3 | |
Not yet recruiting |
NCT05156502 -
To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser
|
N/A | |
Completed |
NCT02638337 -
Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause
|
Phase 3 | |
Not yet recruiting |
NCT02987647 -
Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream
|
Phase 4 | |
Not yet recruiting |
NCT03782961 -
Evaluation of Viscosity of a Vaginal Moisturizer
|
Phase 4 | |
Withdrawn |
NCT01724242 -
Vaginal DHEA for Women After Breast Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT01697345 -
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
|
Phase 0 | |
Completed |
NCT02269826 -
Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness
|
N/A |